Your browser doesn't support javascript.
loading
Building Capability for Clinical Pharmacology Research in Sub-Saharan Africa.
Gutierrez, M M; Pillai, G; Felix, S; Romero, F; Onyango, K O; Owusu-Agyei, S; Asante, K P; Barnes, K I; Sinxadi, P; Allen, E; Abdulla, S; Masimirembwa, C; Munyoro, M; Yimer, G; Gebre-Mariam, T; Spector, J; Ogutu, B.
Afiliación
  • Gutierrez MM; Novartis Pharma and Novartis Institutes for Biomedical Research, Basel, Switzerland and Cambridge, Massachusetts, USA.
  • Pillai G; Novartis Pharma and Novartis Institutes for Biomedical Research, Basel, Switzerland and Cambridge, Massachusetts, USA.
  • Felix S; Novartis Pharma and Novartis Institutes for Biomedical Research, Basel, Switzerland and Cambridge, Massachusetts, USA.
  • Romero F; Novartis Pharma and Novartis Institutes for Biomedical Research, Basel, Switzerland and Cambridge, Massachusetts, USA.
  • Onyango KO; Kenya Medical Research Institute (KEMRI)/Strathmore University (SU), Nairobi, Kenya.
  • Owusu-Agyei S; Kintampo Health Research Center, Kintampo, Ghana.
  • Asante KP; Kintampo Health Research Center, Kintampo, Ghana.
  • Barnes KI; University of Cape Town, Cape Town, South Africa.
  • Sinxadi P; University of Cape Town, Cape Town, South Africa.
  • Allen E; University of Cape Town, Cape Town, South Africa.
  • Abdulla S; Ifakara Health Institute, Bagamoyo, Tanzania.
  • Masimirembwa C; African Institute of Biomedical Science & Technology, Harare, Zimbabwe.
  • Munyoro M; African Institute of Biomedical Science & Technology, Harare, Zimbabwe.
  • Yimer G; Addis Ababa University/Regional Bioequivalence Center, Addis Ababa, Ethiopia.
  • Gebre-Mariam T; Addis Ababa University/Regional Bioequivalence Center, Addis Ababa, Ethiopia.
  • Spector J; Novartis Pharma and Novartis Institutes for Biomedical Research, Basel, Switzerland and Cambridge, Massachusetts, USA.
  • Ogutu B; Kenya Medical Research Institute (KEMRI)/Strathmore University (SU), Nairobi, Kenya.
Clin Pharmacol Ther ; 102(5): 786-795, 2017 Nov.
Article en En | MEDLINE | ID: mdl-28378903
ABSTRACT
A strong scientific rationale exists for conducting clinical pharmacology studies in target populations because local factors such as genetics, environment, comorbidities, and diet can affect variability in drug responses. However, clinical pharmacology studies are not widely conducted in sub-Saharan Africa, in part due to limitations in technical expertise and infrastructure. Since 2012, a novel public-private partnership model involving research institutions and a pharmaceutical company has been applied to developing increased capability for clinical pharmacology research in multiple African countries.
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Farmacología Clínica / Investigación Biomédica / Asociación entre el Sector Público-Privado Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: Africa Idioma: En Revista: Clin Pharmacol Ther Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Farmacología Clínica / Investigación Biomédica / Asociación entre el Sector Público-Privado Tipo de estudio: Prognostic_studies Límite: Humans País/Región como asunto: Africa Idioma: En Revista: Clin Pharmacol Ther Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos